This panel contains 30 Clostridioides difficile isolates collected in the United States through the Emerging Infections Program at the Centers for Disease Control & Prevention. The selected isolates are a representative set of the top 10 most prevalent PCR-ribotypes collected in 2016.
https://journals.asm.org/doi/10.1128/MRA.01011-20
https://journals.asm.org/doi/10.1128/mra.00302-22
Panel ID: CDI
A Biological Safety Cabinet is recommended for specimen handling to minimize the risk of aerosolization of spores.
MIC
results provided were determined by agar dilution.
MIC results for each antimicrobial agent for an isolate may commonly be ± 1 log2 (doubling dilution) different than what is posted on the FDA & CDC AR Bank website because this is the normal technical variability of antimicrobial susceptibility testing (see J. H. Jorgensen. 1993. J Clin Microbiol. Vol 31[11]: 2841-2844).
